Investing Profile

Jean-François Formela

Photo of Jean-François Formela, Partner at Atlas Venture

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Columbia Business School Network
63 CONNECTIONS
cb
$500K - $5.0M
$2.0M
38
CompanyStageDateRound SizeTotal Raised
Triveni Bio
Series BOct 2024$120M
Series AOct 2023$92M
$210M
Scorpion Therapeutics
Series CJul 2024$150M
Series BJan 2021$160M
Series AOct 2020$110M
$420M
Co-investors: Paulina Hill (Polaris Partners), Arjun Goyal (Vida Ventures), Albert Cha (Frazier Healthcare Partners)
Korro Bio
Series BJan 2022$120M
Series ASep 2020$92M
SeedJan 2018
$210M
Triplet Therapeutics
Series ADec 2019$49M
$49M
Co-investors: Shinichiro Fuse
IFM Therapeutics
Series UnknownDec 2019$56M
Series AJun 2016$27M
$83M
Co-investors: Paulina Hill (Polaris Partners)
Spero Therapeutics
Series CMar 2017$52M
Series BFeb 2016$30M
Series AJun 2015$30M
Series AApr 2014$3M
SeedDec 2013
SeedJan 2010
$120M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Vikas Goyal (SR One), Michael Gladstone (Atlas Venture), Reza Halse (RA Capital)
Translate Bio
Series CJan 2017$51M
Series BJul 2015$64M
Series AJan 2012$21M
$140M
Co-investors: John Hamer (DCVC (Data Collective))
Intellia Therapeutics
Series BSep 2015$70M
Series ANov 2014$15M
$85M
Co-investors: Carl Gordon (OrbiMed)
Partner Atlas Venture1993 - Present
Senior Director Schering-Plough1989 - 1993
Universite de Paris School of Medicine MD
Columbia Business School MBA